Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice

Journal of Ethnopharmacology

Volumn 146, Issue 2, 2013, Pages 600-607

  Oh, Hee Kyong ^a,b   Park, Se Jin ^a   Bae, Shin Gil ^a   Kim, Min Jeong ^a   Jang, Jung Hwa ^a   Ahn, Young Je ^a   Woo, Hyun ^a   Kwon, Guyoung ^a   Ryu, Jong Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Cognition; Kami ondam tang; MK 801; Prepulse inhibition; Schizophrenia

Indexed keywords

DIZOCILPINE; HERBACEOUS AGENT; KAMI ONDAM TANG; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PROTEIN EXPRESSION; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; SENSORY GATING; STARTLE REFLEX; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; COGNITION DISORDERS; DIZOCILPINE MALEATE; DRUGS, CHINESE HERBAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; MALE; MEMORY; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-AKT; SOCIAL BEHAVIOR; STARTLE REACTION;

ANIMALIA; MUS;

EID: 84875232130     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.01.032     Document Type: Article

References (54)

1. T. Abekawa, K. Ito, S. Nakagawa, Y. Nakato, and T. Koyama Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents Schizophrenia Research 125 2011 77 87
2. A. Adell, L. Jimenez-Sanchez, X. Lopez-Gil, and T. Romon Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophrenia Bulletin 38 2012 9 14
3. S.E. Ahmari, V.B. Risbrough, M.A. Geyer, and H.B. Simpson Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder Neuropsychopharmacology 37 2012 1216 1223
4. Y.M. Ahn, M.S. Seo, S.H. Kim, Y. Kim, S.C. Yoon, Y.S. Juhnn, and Y.S. Kim Increased phosphorylation of Ser473-Akt, Ser9-GSK-3β and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection International Journal of Neuropsychopharmacology 8 2005 607 613 (Pubitemid 41400892)
5. A.M. Barr, S.B. Powell, A. Markou, and M.A. Geyer Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats Neuropharmacology 51 2006 457 465 (Pubitemid 44215953)
6. 1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats International Journal of Neuropsychopharmacology 12 2009 873 883
7. M. Cai, B.Y. Shin, D.H. Kim, J.M. Kim, S.J. Park, C.S. Park, H. Won do, N.D. Hong, D.H. Kang, Y. Yutaka, and J.H. Ryu Neuroprotective effects of a traditional herbal prescription on transient cerebral global ischemia in gerbils Journal of Ethnopharmacology 138 2011 723 730
8. V. Castagne, P.C. Moser, and R.D. Porsolt Preclinical behavioral models for predicting antipsychotic activity Advances in Pharmacology 57 2009 381 418
9. P.A. Csomor, R.R. Stadler, J. Feldon, B.K. Yee, M.A. Geyer, and F.X. Vollenweider Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels Neuropsychopharmacology 33 2008 497 512
10. M. Davis, D.S. Gendelman, M.D. Tischler, and P.M. Gendelman A primary acoustic startle circuit: lesion and stimulation studies Journal of Neuroscience 2 1982 791 805 (Pubitemid 12064613)
11. J.R. Field, A.G. Walker, and P.J. Conn Targeting glutamate synapses in schizophrenia Trends in Molecular Medicine 17 2011 689 698
12. M. Fioravanti, O. Carlone, B. Vitale, M.E. Cinti, and L. Clare A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia Neuropsychology Review 15 2005 73 95 (Pubitemid 41428110)
13. S.B. Floresco, M.A. Geyer, L.H. Gold, and A.A. Grace Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia Schizophrenia Bulletin 31 2005 888 894 (Pubitemid 41437783)
14. Z. Freyberg, S.J. Ferrando, and J.A. Javitch Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action American Journal of Psychiatry 167 2010 388 396
15. C.S. Gama, L. Canever, B. Panizzutti, C. Gubert, L. Stertz, R. Massuda, M. Pedrini, D.F. de Lucena, R.D. Luca, D.B. Fraga, A.S. Heylmann, P.F. Deroza, and A.I. Zugno Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia Schizophrenia Research 141 2012 162 167
16. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117 154 (Pubitemid 32702206)
17. A. Gogos, M. van den Buuse, and S. Rossell Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI International Journal of Neuropsychopharmacology 12 2009 1249 1259
18. J.G. Hong, D.H. Kim, S.J. Park, J.M. Kim, M. Cai, X. Liu, C.H. Lee, and J.H. Ryu The memory-enhancing effects of Kami-ondam-tang in mice Journal of Ethnopharmacology 137 2011 251 256
19. D. Ishii, D. Matsuzawa, N. Kanahara, S. Matsuda, C. Sutoh, H. Ohtsuka, K. Nakazawa, M. Kohno, K. Hashimoto, M. Iyo, and E. Shimizu Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway Neuroscience Letter 471 2010 53 57
20. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry 148 1991 1301 1308
21. D.C. Javitt, S.R. Zukin, U. Heresco-Levy, and D. Umbricht Has an angel shown the way? etiological and therapeutic implications of the PCP/NMDA model of schizophrenia Schizophrenia Bulletin 38 2012 958 966
22. C.A. Jones, D.J. Watson, and K.C. Fone Animal models of schizophrenia British Journal of Pharmacology 164 2011 1162 1194
23. C.S. Karam, J.S. Ballon, N.M. Bivens, Z. Freyberg, R.R. Girgis, J.E. Lizardi-Ortiz, S. Markx, J.A. Lieberman, and J.A. Javitch Signaling pathways in schizophrenia: emerging targets and therapeutic strategies Trends in Pharmacological Sciences 31 2010 381 390
24. A receptor blockade enhances memory consolidation by increasing hippocampal BDNF levels Neuropsychopharmacology 37 2012 422 433
25. 6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism Neuropharmacology 47 2004 195 204 (Pubitemid 38824643)
26. J.A. Lieberman, T.S. Stroup, J.P. McEvoy, M.S. Swartz, R.A. Rosenheck, D.O. Perkins, R.S. Keefe, S.M. Davis, C.E. Davis, B.D. Lebowitz, J. Severe, and J.K. Hsiao Effectiveness of antipsychotic drugs in patients with chronic schizophrenia New England Journal of Medicine 353 2005 1209 1223 (Pubitemid 41345943)
27. X. Lopez-Gil, Z. Babot, M. Amargos-Bosch, C. Sunol, F. Artigas, and A. Adell Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat Neuropsychopharmacology 32 2007 2087 2097 (Pubitemid 47417703)
28. K. Ludewig, M.A. Geyer, and F.X. Vollenweider Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia Biological Psychiatry 54 2003 121 128 (Pubitemid 36859771)
29. S. Maehara, S. Okuda, and H. Ohta Ameliorative effect of N-desmethylclozapine in animal models of social deficits and cognitive functions Brain Research Bulletin 86 2011 146 151
30. S. Miyamoto, G.E. Duncan, C.E. Marx, and J.A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Molecular Psychiatry 10 2005 79 104 (Pubitemid 40139590)
31. S. Miyamoto, N. Miyake, L.F. Jarskog, W.W. Fleischhacker, and J.A. Lieberman Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents Molecular Psychiatry 17 2012 1206 1227
32. P.J. Moberg, R. Agrin, R.E. Gur, R.C. Gur, B.I. Turetsky, and R.L. Doty Olfactory dysfunction in schizophrenia: a qualitative and quantitative review Neuropsychopharmacology 21 1999 325 340 (Pubitemid 29333071)
33. R. Molteni, F. Calabrese, G. Racagni, F. Fumagalli, and M.A. Riva Antipsychotic drug actions on gene modulation and signaling mechanisms Pharmacology and Therapeutics 124 2009 74 85
34. S. Moriguchi, F. Han, O. Nakagawasai, T. Tadano, and K. Fukunaga Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice Journal of Neurochemistry 97 2006 22 29
35. A. Naert, Z. Callaerts-Vegh, and R. D'Hooge Nocturnal hyperactivity, increased social novelty preference and delayed extinction of fear responses in post-weaning socially isolated mice Brain Research Bulletin 85 2011 354 362
36. O. Nakagawasai, F. Yamadera, K. Iwasaki, H. Arai, R. Taniguchi, K. Tan-No, H. Sasaki, and T. Tadano Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice Neuroscience 125 2004 233 241 (Pubitemid 38402176)
37. O. Nakagawasai, F. Yamadera, K. Iwasaki, T. Asao, K. Tan-No, F. Niijima, H. Arai, and T. Tadano Preventive effect of kami-untan-to on performance in the forced swimming test in thiamine-deficient mice: relationship to functions of catecholaminergic neurons Behavioural Brain Research 177 2007 315 321 (Pubitemid 46149899)
38. 1 agonist C-APB in mice Psychopharmacology 145 1999 237 250 (Pubitemid 29393473)
39. W. Perry, A. Minassian, B. Henry, M. Kincaid, J.W. Young, and M.A. Geyer Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm Psychiatry Research 178 2010 84 91
40. W. Perry, A. Minassian, B. Lopez, L. Maron, and A. Lincoln Sensorimotor gating deficits in adults with autism Biological Psychiatry 61 2007 482 486 (Pubitemid 46185328)
41. R.D. Porsolt, P.C. Moser, and V. Castagne Behavioral indices in antipsychotic drug discovery Journal of Pharmacology and Experimental Therapeutics 333 2010 632 638
42. S.B. Powell, J.W. Young, J.C. Ong, M.G. Caron, and M.A. Geyer Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice Behavioural Pharmacology 19 2008 562 565
43. S.B. Powell, X. Zhou, and M.A. Geyer Prepulse inhibition and genetic mouse models of schizophrenia Behavioural Brain Research 204 2009 282 294
44. J. Rathbone, L. Zhang, M. Zhang, J. Xia, X. Liu, Y. Yang, and C.E. Adams Chinese herbal medicine for schizophrenia: cochrane systematic review of randomised trials British Journal of Psychiatry 190 2007 379 384 (Pubitemid 46706949)
45. 2 exert both additive and opposing influences on defensive startle behavior Journal of Neuroscience 24 2004 6545 6552 (Pubitemid 38971703)
46. B receptors in MK-801-stimulated release of glutamate in rat prefrontal cortex Neuropharmacology 63 2012 575 581
47. M.D. Rubio, J.B. Drummond, and J.H. Meador-Woodruff Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments Biomolecules and Therapeutics 20 2012 1 18
48. C.I. Rupp Olfactory function and schizophrenia: an update Current Opinion in Psychiatry 23 2010 97 102
49. B.I. Turetsky, P. Crutchley, J. Walker, R.E. Gur, and P.J. Moberg Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia? Schizophrenia Research 115 2009 8 11
50. B.I. Turetsky, C.G. Hahn, K. Borgmann-Winter, and P.J. Moberg Scents and nonsense: olfactory dysfunction in schizophrenia Schizophrenia Bulletin 35 2009 1117 1131
51. J. van Os, and S. Kapur Schizophrenia Lancet 374 2009 635 645
52. Q. Wang, K. Iwasaki, T. Suzuki, H. Arai, Y. Ikarashi, T. Yabe, K. Toriizuka, T. Hanawa, H. Yamada, and H. Sasaki Potentiation of brain acetylcholine neurons by Kami-Untan-To (KUT) in aged mice: implications for a possible antidementia drug Phytomedicine 7 2000 253 258 (Pubitemid 30618488)
53. T. Wykes, C. Reeder, S. Landau, B. Everitt, M. Knapp, A. Patel, and R. Romeo Cognitive remediation therapy in schizophrenia: randomised controlled trial British Journal of Psychiatry 190 2007 421 427 (Pubitemid 46706955)
54. L. Zhang, Y. Shirayama, M. Iyo, and K. Hashimoto Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine Neuropsychopharmacology 32 2007 2004 2010 (Pubitemid 47258509)